Autoimmune Disease Diagnosis Market Size, Business Opportunity and Future Demand by 2028 | IMARC Group

IMARC Group, a leading market research company, has recently releases report titled "Autoimmune Disease Diagnosis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" The study provides a detailed analysis of the industry, including the global autoimmune disease diagnosis market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the autoimmune disease diagnosis market?

The global autoimmune disease diagnosis market size reached US$ 3.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.

What is an autoimmune disease diagnosis?

An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.

Request for a sample copy of this report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample

What are the growth prospects and trends in the autoimmune disease diagnosis industry?

The global market is primarily driven by the growing prevalence of numerous autoimmune disorders, along with the increasing demand for precise and efficient diagnostic solutions. This has led to the adoption of advanced technologies to conduct multiple tests simultaneously with faster and accurate results. These technologies are also focused on providing an improved diagnosis with higher sensitivity, which is providing an impetus to the market growth. In addition to this, there has been a rising preference for laboratory automation. This, along with the increasing healthcare expenditure, is acting as a major growth-inducing factor. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the diagnosis and treatment of autoimmune disorders. Several research and diagnostics institutes are also investing in programs that aim to develop improved diagnostic methods and novel therapeutic solutions for these medical disorders, which, in turn, is expected to create a positive outlook for the market. On account of the aforementioned factors, the market is expected to grow at a CAGR of 5.8% during 2023-2028.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Type Insights:

Consumables and Assay Kits
Instruments

Disease Type Insights:

Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Others
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Others

Test Type Insights:

Routine Laboratory Tests
Inflammatory Markers
Autoantibodies and Immunologic Tests
Others

End-User Insights:

Clinical Laboratories
Hospitals
Others

Breakup by Region:

North America (U.S. Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East Africa

Who are the key players operating in the industry?

The report covers the major market players including:

Abbott Laboratories
GROUP
Danaher Corp.
bioMérieux SA
Bio-Rad Laboratories
PerkinElmer Inc.
Hemagen Diagnostics, Inc.
Inova Diagnostics, Inc.
Myriad Genetics, Inc.
Quest Diagnostics Incorporated
Siemens Healthineers AG
SQI Diagnostics
Thermo Fisher Scientific Inc.
Trinity Biotech plc.

Ask Analyst for Customization and Browse full report with TOC List of Figure: https://www.imarcgroup.com/request?type=report&id=2250&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.